SHANGHAI SERUM BIO-TECHNOLOGY
68816328.8211.45% ( +2.96 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: SHANGHAI SERUM BIO-TECHNOLOGY(688163) the Revenue is 27.09 M (+5.75%);the EBIT is -1.624 M (-259%);the EPS is 0.01 (-66.67%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.03B5.75%
----
----
EBIT
-0.00B259.01%
----
----
EPS
0.0166.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf